A Promising Drug Target: CMC1, a Mitochondrial Metabolite-Like Protein

Target Name: CMC1

NCBI ID: G152100

CMC1

A Promising Drug Target: CMC1, a Mitochondrial Metabolite-Like Protein

Metabolism is a critical process that occurs in all living organisms to maintain life. The mitochondria, as the primary energy-producing organ in the cell, are involved in this process. One of the key proteins involved in mitochondrial metabolism is CMC1 (Mitochondrial Metabolite-Like Protein), which is a protein that can be produced in the mitochondria and has been shown to play a critical role in various cellular processes.

Recent studies have identified CMC1 as a potential drug target or biomarker, which could be useful in the development of new treatments for various diseases. In this article, we will explore the biology of CMC1 and its potential as a drug target.

biology and function of CMC1

CMC1, also known as Mitochondrial Metabolite-Like Protein 1 (MMP-1), is a protein that is produced in the mitochondria and has been shown to play a critical role in various cellular processes. It is a 21-kDa protein that contains 115 amino acid residues and has a calculated pI of 9.6. CMC1 is localized to the mitochondria, where it is involved in the formation of the mitochondrial inner membrane and in the production of various cellular organelles, including the mitochondrial fission complex, which is responsible for the process of mitochondrial fission.

In addition to its role in the formation of the mitochondrial inner membrane, CMC1 has also been shown to play a critical role in the regulation of mitochondrial dynamics. It has been shown to interact with various

Protein Name: C-X9-C Motif Containing 1

Functions: Component of the MITRAC (mitochondrial translation regulation assembly intermediate of cytochrome c oxidase complex) complex, that regulates cytochrome c oxidase assembly

The "CMC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CMC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets